BGB-A317-A445-101
Completed
Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid Tumors
BeOne Study ID 
BGB-A317-A445-101
ClinicalTrials.gov ID
EudraCT Number
2022-501177-39-00
China Drug Trials ID
CTR20220453
Study Overview
Sex:
All
Age: 18 Years / N/A
No Study Documents
Study Overview
Sex:
All
Age: 18 Years / N/A
No Study Documents